Skip to main navigation

Overview
Corporate
News & Events
Stock Information
Financial Information
- SEC Filings
- Quarterly Results
IR Resources

News & Events

News Releases

News Releases

All
2026
2025
2024
2023
2022
2021
2020
2019

2021.10.21

Adagene to Participate in the Jefferies Virtual China Biotech Summit

2021.09.02

Adagene to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

2021.08.26

Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates

2021.08.19

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)

2021.08.12

Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board

Pagination

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Displaying 86 - 90 of 112

Shareholder Tools

© 2026 Adagene Inc.

Footer Bottom

Home
Privacy
Terms of Use
Contact
Site Credits
LinkedIn